Is Drotrecogin alfa (activated) for adults with severe sepsis, cost-effective in routine clinical practice?

被引：0
|
作者：
M Zia Sadique
Richard Grieve
David A Harrison
Brian H Cuthbertson
Kathryn M Rowan
机构：
[1] London School of Hygiene and Tropical Medicine,Department of Health Services Research and Policy, WC1H 9SH
[2] Research Centre,Intensive Care National Audit &WC1H 9HR
[3] Sunnybrook Health Sciences Centre,Department of Critical Care Medicine, M4N 3M5
来源：
Critical Care | / 15卷
关键词：
Severe Sepsis; Critical Care; Additional Data File; Acute Hospital; Critical Care Unit;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Drotrecogin alfa (activated): a novel therapeutic strategy for severe sepsis
    Pastores, SM
    POSTGRADUATE MEDICAL JOURNAL, 2003, 79 (927) : 5 - 10
  • [42] Selecting patients with severe sepsis for drotrecogin alfa (activated) therapy
    Sollet, JP
    Garber, GE
    AMERICAN JOURNAL OF SURGERY, 2002, 184 (6A): : 11S - 18S
  • [43] Drotrecogin alfa (activated) in severe sepsis after cardiac surgery
    Bubenek, S.
    Stelian, E.
    Craciun, M.
    Miclea, I.
    Sefu, F.
    Boros, C.
    Timofiev, L.
    Tulbure, D.
    EUROPEAN JOURNAL OF ANAESTHESIOLOGY, 2004, 21 : 167 - 168
  • [44] Evaluation of the cost-effectiveness of drotrecogin alfa (activated) for the treatment of severe sepsis in the United Kingdom
    Green, C
    Dinnes, J
    Takeda, AL
    Cuthbertson, BH
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2006, 22 (01) : 90 - 100
  • [45] Cost-effectiveness of drotrecogin alfa (activated) in the treatment of severe sepsis with multiple organ failure
    França, LR
    Launois, R
    Le Lay, K
    Aegerter, P
    Bouhassira, M
    Meshaka, P
    Guidet, B
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2006, 22 (01) : 101 - 108
  • [46] Drotrecogin alfa (activated) in severe sepsis: A systematic review and new cost-effectiveness analysis
    Costa V.
    Brophy J.M.
    BMC Anesthesiology, 7 (1)
  • [47] Safety, pharmacokinetics, and pharmacodynamics of drotrecogin alfa (activated) in children with severe sepsis
    Weiss, KD
    PEDIATRICS, 2004, 113 (01) : 134 - 134
  • [48] Patterns of survival in patients with severe sepsis treated with drotrecogin alfa (activated)
    Williams, MD
    Macias, W
    Nelson, D
    CHEST, 2004, 126 (04) : 723S - 723S
  • [49] Successful Treatment with Drotrecogin alfa (activated) in a Pregnant Patient with Severe Sepsis
    Eppert, Heather D.
    Goddard, Kara B.
    King, Crystal L.
    PHARMACOTHERAPY, 2011, 31 (03): : 333 - 333
  • [50] Drotrecogin alfa (activated) - A pharmacoeconomic review of its use in severe sepsis
    Frampton, JE
    Foster, RH
    PHARMACOECONOMICS, 2004, 22 (07) : 445 - 476
12345